New research shows that non-steroidal anti-inflammatory drugs (NSAIDs) reduced both antibody and inflammatory responses to SARS-CoV-2 infection in mice.
Exercising muscle combats chronic inflammation on its own
Biomedical engineers have demonstrated that human muscle has an innate ability to ward off damaging effects of chronic inflammation when exercised. The discovery was made possible through the use of lab-grown, engineered human muscle, demonstrating the…
Rhesus macaques develop promising immune response to SARS-CoV-2
In a promising result for the success of vaccines against COVID-19, rhesus macaque monkeys infected with the human coronavirus SARS-CoV-2 developed protective immune responses that might be reproduced with a vaccine.
New combination of immunotherapies shows great promise for treating lung cancer
Researchers have established in lab settings that a novel combination of two forms of immunotherapy can be highly effective for treating lung cancer, which causes more deaths than any other form of cancer.
Scientists solve a 100-year-old mystery about cancer
A long-standing mystery is why fast-growing cells, like cancer cells and immune cells, rely on a seemingly inefficient form of metabolizing glucose to power their activities. In a new study, scientists now offer a compelling solution.
Developmental origins of eczema and psoriasis discovered
Scientists have created a highly detailed map of skin, which reveals that cellular processes from development are re-activated in cells from patients with eczema and psoriasis inflammatory skin diseases. The study offers potential new drug targets for …
New insights into the link between sunlight exposure and kidney damage
A new collaborative study reveals unexpected insights into how skin exposure to ultraviolet light can worsen clinical symptoms in autoimmune diseases such as lupus.
Creating a safe CAR T-Cell therapy to fight solid tumors in children
Scientists modify CAR T-Cell therapy, making it more effective and less toxic, for possible use in solid tumors such as neuroblastoma.
A closer look at T cells reveals big differences in mild vs. severe COVID-19 cases
How long does immunity to SARS-CoV-2 last following infection? Researchers have uncovered an interesting clue. Their new study suggests that people with severe COVID-19 cases may be left with more of the protective ‘memory’ T cells needed to fight rein…
Study defines small-cell lung cancer subtypes and distinct therapeutic vulnerabilities for each type
Researchers have developed the first comprehensive framework to classify small-cell lung cancer (SCLC) into four unique subtypes, based on gene expression, and have identified potential therapeutic targets for each type in a study.